Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
05.11.25
/
50%
€268.25
Target price
05.11.26
€348.04
Performance (%)
20.50%
Price
06.03.26
€318.35
Summary
This prediction is currently active. The prediction currently has a performance of 20.50%. Dividends of €4.90 are taken into consideration when calculating the performance. This prediction currently runs until 05.11.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -3.105% | -3.105% |
| iShares Core DAX® | -6,02 % | -4,60 % |
| iShares Nasdaq 100 | 0,51 % | 0,16 % |
| iShares Nikkei 225® | -7,16 % | -2,21 % |
| iShares S&P 500 | -0,26 % | -0,84 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $405.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat